Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia
Open Access
- 1 October 2014
- journal article
- Published by Taylor & Francis Ltd in Neuropsychiatric Disease and Treatment
- Vol. 10, 1973-1978
- https://doi.org/10.2147/ndt.s69784
Abstract
Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia Yuka Sugawara Kikuchi, Wataru Sato, Keiichiro Ataka, Kiwamu Yagisawa, Yuki Omori, Takashi Kanbayashi, Tetsuo Shimizu Department of Neuropsychiatry, Akita University Graduate School of Medicine, Hondo, Akita, Japan Purpose: We describe electroencephalography (EEG) abnormalities and seizures associated with clozapine treatment in Japanese patients with schizophrenia and retrospectively compare EEG results and total Positive and Negative Syndrome Scale (PANSS [T]) scores before and after treatment. Methods: Twenty-six patients with treatment-resistant schizophrenia were enrolled in this study. EEG measurements were obtained prior to clozapine treatment and every 4 weeks thereafter. EEG measurements were also obtained at the time of seizure. After seizures or EEG abnormalities were noted, additional EEGs were performed every 2 weeks. PANSS (T) scores were used to determine clozapine treatment outcome. Results: All 26 patients had normal baseline EEG measurements, and ten patients (38.5%) later manifested EEG abnormalities. The mean age was significantly lower than in the abnormal EEG group. Six patients (23.1%) experienced seizures. The mean dose of clozapine at the first occurrence of seizure was 383.3 mg/day. Five of six patients who experienced seizures in this study were successfully treated with valproate or lamotrigine without discontinuation of clozapine. The one patient who continued to experience seizures was successfully treated without antiepileptic drugs. The mean baseline PANSS (T) scores were not significantly different between the normal and abnormal EEG groups, but the mean score in the abnormal EEG group was significantly lower than that in the normal EEG group at the final follow-up (P=0.02). Conclusion: EEG abnormalities may appear in younger patients, and our findings indicate that there is no need to discontinue clozapine when seizures occur. EEG abnormalities that appeared after clozapine treatment were associated with a good clinical response. Keywords: treatment-resistant schizophrenia, side effects, PANSS, convulsionsKeywords
This publication has 27 references indexed in Scilit:
- Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: Results from a 12-week, flexible dose study using raters masked to antipsychotic choiceAsian Journal of Psychiatry, 2012
- Electroencephalographic Abnormalities in Clozapine-Treated Patients: A Cross-Sectional StudyPsychiatry Investigation, 2011
- The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptorsNeuropharmacology, 2004
- EEG Abnormalities During Treatment With Typical and Atypical AntipsychoticsAmerican Journal of Psychiatry, 2002
- Gabapentin Prophylaxis of Clozapine-Induced SeizuresAmerican Journal of Psychiatry, 2000
- Seizures during clozapine therapy.1994
- EEG alterations in patients treated with clozapine in relation to plasma levelsPsychopharmacology, 1994
- EEG Alterations and Seizures during Treatment with ClozapinePharmacopsychiatry, 1993
- Prolonged postictal encephalopathy in two patients with clozapine- induced seizuresThe Journal of Neuropsychiatry and Clinical Neurosciences, 1992
- Clozapine and seizuresAmerican Journal of Psychiatry, 1990